Scarica l'app Stockscreener
1.11
0.89%
-0.01
Dopo l'orario di chiusura:
1.13
0.02
+1.80%
Precedente Chiudi:
$1.12
Aprire:
$1.11
Volume 24 ore:
2.65M
Relative Volume:
0.68
Capitalizzazione di mercato:
$246.29M
Reddito:
$95,000
Utile/perdita netta:
$-327.27M
Rapporto P/E:
-0.5236
EPS:
-2.12
Flusso di cassa netto:
$-239.25M
1 W Prestazione:
-5.93%
1M Prestazione:
+0.91%
6M Prestazione:
-41.58%
1 anno Prestazione:
-56.98%
Intervallo 1D:
$1.06
$1.1371
Intervallo di 1 settimana:
$1.06
$1.2065
Portata 52W:
$0.8621
$3.78
Allogene Therapeutics Inc Stock (ALLO) Company Profile
Nome
Allogene Therapeutics Inc
Settore
Industria
Telefono
(650) 457-2700
Indirizzo
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Confronta ALLO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALLO
Allogene Therapeutics Inc
|
1.11 | 248.51M | 95,000 | -327.27M | -239.25M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Allogene Therapeutics Inc Stock (ALLO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-08-08 | Ripresa | Oppenheimer | Outperform |
| 2024-05-31 | Iniziato | Piper Sandler | Overweight |
| 2024-01-05 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-01-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-08 | Iniziato | Citigroup | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-21 | Iniziato | Bernstein | Mkt Perform |
| 2023-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-01-06 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-12-12 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-08-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-15 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-06-03 | Iniziato | Robert W. Baird | Neutral |
| 2022-02-28 | Reiterato | B. Riley Securities | Buy |
| 2021-10-20 | Iniziato | Cowen | Outperform |
| 2021-10-08 | Downgrade | Goldman | Buy → Neutral |
| 2021-10-08 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-06-21 | Ripresa | Jefferies | Buy |
| 2021-05-20 | Aggiornamento | Truist | Hold → Buy |
| 2021-05-14 | Iniziato | B. Riley Securities | Buy |
| 2021-01-26 | Aggiornamento | Stifel | Hold → Buy |
| 2020-12-10 | Ripresa | H.C. Wainwright | Buy |
| 2020-11-24 | Iniziato | BofA Securities | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-06-01 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-05-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-19 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2020-05-15 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-14 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-14 | Downgrade | SunTrust | Buy → Hold |
| 2020-04-13 | Iniziato | SunTrust | Buy |
| 2020-03-13 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-05 | Iniziato | Stifel | Hold |
| 2020-02-24 | Iniziato | Berenberg | Hold |
| 2019-12-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-11-04 | Iniziato | Canaccord Genuity | Buy |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-06-05 | Iniziato | ROTH Capital | Neutral |
| 2019-05-31 | Iniziato | Guggenheim | Neutral |
| 2019-05-23 | Iniziato | Stifel | Hold |
| 2019-03-29 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Allogene Therapeutics Inc Borsa (ALLO) Ultime notizie
What MACD signals say about Allogene Therapeutics Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Should you hold or exit Allogene Therapeutics Inc. nowTrade Ideas & Low Risk Investment Opportunities - Newser
How institutional ownership impacts Allogene Therapeutics Inc. stockVolume Spike & Weekly High Potential Alerts - Newser
Key metrics from Allogene Therapeutics Inc.’s quarterly data2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Should you wait for a breakout in Allogene Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
What earnings revisions data tells us about Allogene Therapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - Newser
Is it too late to sell Allogene Therapeutics Inc.Quarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser
Has Allogene Therapeutics Inc. found a price floorJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
Why Allogene Therapeutics Inc. is moving todayPortfolio Performance Report & High Accuracy Buy Signal Tips - Newser
Exit strategy if you’re trapped in Allogene Therapeutics Inc.Market Trend Review & High Conviction Buy Zone Picks - Newser
Is Allogene Therapeutics Inc. reversing from oversold territoryJuly 2025 Short Interest & Smart Money Movement Alerts - Newser
What momentum shifts mean for Allogene Therapeutics Inc.Weekly Trade Analysis & Low Drawdown Momentum Ideas - Newser
Will Allogene Therapeutics Inc. outperform the marketEarnings Growth Report & Free Community Consensus Stock Picks - Newser
Allogene Therapeutics Inc. stock trend outlook and recovery pathWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Allogene Therapeutics Inc. stock outlook for YEAREarnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Evaluating Allogene Therapeutics Inc. with trendline analysisPortfolio Profit Report & Smart Allocation Stock Tips - Newser
Is Allogene Therapeutics Inc. building a consolidation baseWeekly Trading Summary & Daily Profit Focused Stock Screening - Newser
Allogene Therapeutics’ SWOT analysis: stock faces challenges amid promising pipeline - Investing.com
Will Allogene Therapeutics Inc. outperform its industry peersJuly 2025 Snapshot & Weekly High Return Stock Forecasts - khodrobank.com
Comparing Allogene Therapeutics Inc. in custom built stock radarsJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
Can Allogene Therapeutics Inc. sustain earnings growthJuly 2025 Decliners & Weekly High Return Forecasts - khodrobank.com
Visual analytics tools that track Allogene Therapeutics Inc. performanceWeekly Trend Summary & Technical Entry and Exit Tips - Newser
Full technical analysis of Allogene Therapeutics Inc. stock2025 Market Outlook & Risk Managed Investment Signals - Newser
Backtesting results for Allogene Therapeutics Inc. trading strategiesJuly 2025 Macro Moves & Community Supported Trade Ideas - Newser
How to recover losses in Allogene Therapeutics Inc. stockTrade Ideas & Risk Managed Investment Entry Signals - Newser
Using Ichimoku Cloud for Allogene Therapeutics Inc. technicalsInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How to manage a losing position in Allogene Therapeutics Inc.CPI Data & Reliable Breakout Forecasts - Newser
Applying Wyckoff theory to Allogene Therapeutics Inc. stockJuly 2025 Outlook & Technical Pattern Alert System - Newser
Allogene Therapeutics Earnings Call: Progress Amid Challenges - TipRanks
Momentum divergence signals in Allogene Therapeutics Inc. chartEarnings Beat & Technical Pattern Alert System - Newser
Visualizing Allogene Therapeutics Inc. stock with heatmapsJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Volatility clustering patterns for Allogene Therapeutics Inc.July 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Ranking Allogene Therapeutics Inc. among high performing stocks via tools2025 Momentum Check & Weekly Return Optimization Alerts - Newser
Real time pattern detection on Allogene Therapeutics Inc. stockM&A Rumor & Technical Entry and Exit Alerts - Newser
How to track smart money flows in Allogene Therapeutics Inc.July 2025 Intraday Action & Community Trade Idea Sharing - Newser
Allogene Therapeutics Inc Azioni (ALLO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):